IBT Laboratories' Series A Round

IBT Laboratories raised a round of funding on December 24, 2004. Investors include Ampersand Capital Partners.

IBT is an international allergy and immunology laboratory. IBT offers esoteric molecular and cellular immunology services for pharmaceutical clinical trials and patient care diagnostic testing. In…

Articles about IBT Laboratories' Series A Round: